Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali (4 cases). Bull Soc Pathol Exotique Filiales. 1965;58(6):1169–75.
Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87(1):63–70.
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81. https://doi.org/10.1182/blood-2016-01-690636.
Article CAS PubMed PubMed Central Google Scholar
Mahzoni P, Zavareh MH, Bagheri M, Hani N, Moqtader B. Intracranial Rosai–Dorfman Disease. J Res Med Sci. 2012;17(3):304–7.
PubMed PubMed Central Google Scholar
Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19–73.
Kutlubay Z, Bairamov O, Sevim A, Demirkesen C, Mat MC. Rosai–Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature. Am J Dermatopathol. 2014;36(4):353–7. https://doi.org/10.1097/DAD.0b013e31829e5564.
Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, Fletcher CD, McKee PH. Cutaneous Rosai–Dorfman disease is a distinct clinical entity. Am J Dermatopathol. 2002;24(5):385–91. https://doi.org/10.1097/00000372-200210000-00001.
Sodhi KS, Suri S, Nijhawan R, Kang M, Gautam V. Rosai–Dorfman disease: unusual cause of diffuse and massive retroperitoneal lymphadenopathy. Br J Radiol. 2005;78(933):845–7. https://doi.org/10.1259/bjr/23127241.
Article CAS PubMed Google Scholar
Bruce-Brand C, Schneider JW, Schubert P. Rosai–Dorfman disease: an overview. J Clin Pathol. 2020;73(11):697–705. https://doi.org/10.1136/jclinpath-2020-206733.
Article CAS PubMed Google Scholar
Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai–Dorfman-Destombes disease. Blood. 2018;131(26):2877–90. https://doi.org/10.1182/blood-2018-03-839753.
Article CAS PubMed PubMed Central Google Scholar
Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Colby T, Arnaud L, Haroche J. Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease. Blood. 2014;124(4):483–92. https://doi.org/10.1182/blood-2014-03-561381.
Article CAS PubMed PubMed Central Google Scholar
Pi Ca Rsic J, Jaffe R (2018) Pathology of histiocytic disorders and neoplasms and related disorders
Elshikh M, Schellingerhout D, Rayan J, Taher A, Elsayes AK, Mujtaba B, Garg N. Disease characteristics, radiologic patterns, comorbid diseases, and ethnic differences in 32 patients with Rosai–Dorfman disease. J Comput Assist Tomogr. 2020;44(3):450–61. https://doi.org/10.1097/rct.0000000000000983.
Vaidya T, Mahajan A, Rane S. Multimodality imaging manifestations of Rosai–Dorfman disease. Acta Radiol Open. 2020;9(8):2058460120946719. https://doi.org/10.1177/2058460120946719.
Article PubMed PubMed Central Google Scholar
Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai–Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. Am J Roentgenol. 2011;196(2):W187-193. https://doi.org/10.2214/ajr.10.4778.
Mahajan S, Nakajima R, Yabe M, Dogan A, Ulaner GA, Yahalom J, Noy A, Diamond EL, Schöder H. Rosai–Dorfman disease-utility of 18F-FDG PET/CT for initial evaluation and follow-up. Clin Nucl Med. 2020;45(6):e260–6. https://doi.org/10.1097/rlu.0000000000003014.
Article PubMed PubMed Central Google Scholar
Sathyanarayanan V, Issa A, Pinto R, Fayad LE, Loghavi S, Hagemeister F, Westin JR. Rosai–Dorfman disease: the MD Anderson cancer center experience. Clin Lymphoma Myeloma Leuk. 2019;19(11):709–14. https://doi.org/10.1016/j.clml.2019.06.013.
Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS. Clinicopathological features, treatment approaches, and outcomes in Rosai–Dorfman disease. Haematologica. 2020;105(2):348–57. https://doi.org/10.3324/haematol.2019.219626.
Article CAS PubMed PubMed Central Google Scholar
Niu Y, Li Y, Wang J, Jin X, Yang D, Huo H, Li W. Laryngeal Rosai–Dorfman disease (sinus histiocytosis with massive lymphadenopathy): a retrospective study of 5 cases. Biomed Res Int. 2017;2017:8521818. https://doi.org/10.1155/2017/8521818.
Article PubMed PubMed Central Google Scholar
Maeda Y, Ichimura K. Rosai–Dorfman disease revealed in the upper airway: a case report and review of the literature. Auris Nasus Larynx. 2004;31(3):279–82. https://doi.org/10.1016/j.anl.2004.03.015.
Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, Villivà N, Mandelli F. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69(1):67–71. https://doi.org/10.1002/ajh.10008.
Lee M, Ryu KH, Baek HJ, Moon JI, Yoon S, An HJ, Nam IC. Rosai–Dorfman disease with infiltration of IgG4-bearing plasma cells presenting as laryngeal-nasal masses and cervical lymphadenopathy: a case report. Medicine. 2021;100(12):e25165. https://doi.org/10.1097/md.0000000000025165.
Article PubMed PubMed Central Google Scholar
Tsang JS, Anthony MP, Wong MP, Wong CS. The use of FDG-PET/CT in extranodal Rosai–Dorfman disease of bone. Skeletal Radiol. 2012;41(6):715–7. https://doi.org/10.1007/s00256-012-1382-9.
Merrell MA, Grenn EE, Orr WS 3rd. Rosai–Dorfman disease of the chest wall following mastectomy for breast cancer. Am Surg. 2022. https://doi.org/10.1177/00031348221091963.
Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT follow-up of Rosai–Dorfman disease. Clin Nucl Med. 2015;40(8):e420-422. https://doi.org/10.1097/rlu.0000000000000853.
Xue Q, Miao W. Spontaneous recovery of Rosai–Dorfman disease on FDG PET/CT. Clin Nucl Med. 2017;42(8):608–9. https://doi.org/10.1097/rlu.0000000000001705.
Zadeh MZ, Wen Z, States LJ, Zhuang H. An isolated osseous Rosai–Dorfman disease shown on FDG PET/CT. Clin Nucl Med. 2019;44(6):485–8. https://doi.org/10.1097/rlu.0000000000002501.
Pucar D, Laskin WB, Saperstein L. Isolated multinodular soft-tissue Rosai–Dorfman disease on FDG PET/CT. Clin Nucl Med. 2018;43(2):e53–5. https://doi.org/10.1097/rlu.0000000000001921.
Liu T, Cao X. Successful treatment of multisystemic Rosai–Dorfman disease with lenalidomide and dexamethasone: a case report. Ann Hematol. 2022;101(6):1351–3. https://doi.org/10.1007/s00277-021-04719-1.
Fathala A, Edathodu J, Bakshi N. FDG PET/CT in the evaluation of a rare case of multisystem involvement in newly diagnosed Rosai–Dorfman-Destombes disease. Saudi J Med Med Sci. 2021;9(2):195–8. https://doi.org/10.4103/sjmms.sjmms_99_20.
Article PubMed PubMed Central Google Scholar
Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET/CT in Erdheim–Chester disease: imaging findings and potential BRAF mutation biomarker. J Nuclear Med. 2018;59(5):774–9. https://doi.org/10.2967/jnumed.117.200741.
Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester disease, Destombes-Rosai–Dorfman disease): from oncogenic mutations to inflammatory disorders. Curr Oncol Rep. 2019;21(7):62. https://doi.org/10.1007/s11912-019-0810-6.
Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS. The Mayo Clinic Histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim–Chester disease, langerhans cell histiocytosis, and Rosai–Dorfman disease. Mayo Clin Proc. 2019;94(10):2054–71. https://doi.org/10.1016/j.mayocp.2019.02.023.
Krishnan A, Nassar A, Nieh PT. Rosai–Dorfman disease presenting as extranodal renal mass. Urology. 2005;66(6):1319. https://doi.org/10.1016/j.urology.2005.06.103.
El Majdoub A, El Houari A, Chbani L, El Fatemi H, Khallouk A, Farih MH. Isolated localization of Rosai Dorfman disease as renal mass: a case report and review of literature. Pan Afr Med J. 2016;24:64. https://doi.org/10.11604/pamj.2016.24.64.6291.
Article PubMed PubMed Central Google Scholar
Laubham MP, Darki A. Rosai–Dorfman disease and left ventricular noncompaction cardiomyopathy: A heart failure conundrum. J Nuclear Cardiol. 2018;25(6):1971–5. https://doi.org/10.1007/s12350-018-1408-3.
O’Gallagher K, Dancy L, Sinha A, Sado D. Rosai–Dorfman disease and the heart. Intractable Rare Diss Res. 2016;5(1):1–5. https://doi.org/10.5582/irdr.2015.01047.
留言 (0)